CME Group Inc. Class A (CME) Peer Comparison
$294.35
$0.87
(0.29%)
As on 28-Oct-2026 11:35EDT
Market cap
$109,927 Mln
Revenue (TTM)
$6,972 Mln
P/E Ratio
25.1
P/B Ratio
3.7
Div. Yield
0.4 %
Edit
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
109,927 | 57,329 | 5,796 | 281,901 | 254,973 |
Revenue ($ Mln) |
6,972 | 9,142 | 870 | 129,757 | 123,485 |
Net Profit ($ Mln) |
4,401.00 | 2,085.00 | 292.08 | 20,525.00 | 22,169.00 |
Net Margin (%) |
63.12 | 22.81 | 33.59 | 15.82 | 17.95 |
RoE (%) |
16.55 | 17.35 | 23.65 | 17.57 | 17.89 |
Price to Earnings |
25.06 | 28.02 | 20.20 | 14.23 | 12.59 |
Price-To-Book |
3.72 | 4.14 | 4.64 | 2.95 | 2.52 |
Income Statement ($ Mln)
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,972.30 | 9,142.00 | 869.60 | 129,757.00 | 123,485.00 |
|
Cost of Revenue
|
1,093.00 | 3,363.00 | 221.55 | 51,091.00 | 52,449.00 |
|
Gross Profit
|
5,613.60 | 3,939.00 | 593.40 | 65,617.00 | 59,396.00 |
|
Operating Expenses
|
1,301.50 | 2,883.00 | 305.93 | 52,019.00 | 40,168.00 |
|
Operating Profit (EBIT)
|
4,577.80 | 2,896.00 | 342.12 | 26,647.00 | 30,868.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
5,771.80 | 2,611.00 | 348.26 | 26,597.00 | 27,907.00 |
|
Provision for Tax
|
1,370.80 | 527.00 | 55.41 | 5,913.00 | 5,738.00 |
|
Profit after Tax (Net Income)
|
4,401.00 | 2,085.00 | 292.08 | 20,525.00 | 22,169.00 |
|
Minority Interest
|
0.00 | 0.00 | -0.60 | -170.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 4,250.00 | 9,787.00 |
Liabilities ($ Mln)
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
26,560.30 | 11,999.00 | 1,274.94 | 117,440.00 | 125,000.00 |
|
Minority Interest
|
0.00 | 0.00 | -0.60 | -170.00 | 0.00 |
|
Non-Current Liabilities
|
9,419.30 | 10,863.00 | 902.16 | -117,440.00 | 382,000.00 |
|
Current Liabilities
|
156,112.90 | 4,517.00 | 83.66 | 0.00 | 1,675,000.00 |
|
Total Liabilities
|
198,548.40 | 31,053.00 | 1,808.61 | 1,420,270.00 | 1,809,320.00 |
Assets ($ Mln)
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
32,954.30 | 22,851.00 | 427.94 | -22,894.00 | 588,000.00 |
|
Current Assets
|
159,138.20 | 4,532.00 | 502.71 | 120,097.00 | 1,594,000.00 |
|
Total Assets
|
198,548.40 | 31,053.00 | 1,808.61 | 1,420,270.00 | 1,809,320.00 |
|
Total Debt*
|
3,425.10 | 9,216.00 | 61.09 | 0.00 | 839,000.00 |
|
Net Current Assets
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cashflow ($ Mln)
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
4,277.10 | 2,255.00 | 382.29 | 48,998.00 | -45,154.00 |
|
Cash Flow from Investing Activities
|
1,498.80 | -1,100.00 | -96.72 | -144,222.00 | -44,227.00 |
|
Cash from Financing Activities
|
56,509.50 | -2,953.00 | -332.37 | 98,314.00 | 66,100.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
12.96 | 8.28 | 17.06 | 3.20 | 2.33 |
|
ROE (%)
|
16.55 | 17.35 | 23.65 | 17.57 | 17.89 |
|
ROA (%)
|
1.28 | 5.93 | 11.04 | 1.21 | 0.71 |
|
EBIT Margin (%)
|
90.33 | 29.71 | 40.33 | 15.51 | 25.06 |
|
Net Margin (%)
|
63.12 | 22.81 | 33.59 | 15.82 | 17.95 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.99 | 11.92 | 3.09 | 15.75 | -2.93 |
|
EBIT Growth (%)
|
25.48 | 14.65 | -5.88 | -4.65 | 45.58 |
|
Net Profit Growth (%)
|
17.33 | 28.31 | 33.05 | 26.87 | 32.99 |
|
EPS Growth (%)
|
17.04 | 30.41 | 38.89 | 27.73 | 39.19 |
|
Book Value Growth (%)
|
-5.34 | 2.58 | -2.71 | 8.33 | 5.46 |
Valuation Ratios
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
24.32 | 31.30 | 27.05 | 16.77 | 16.25 |
|
Price / Book Value
|
3.42 | 4.58 | 5.82 | 2.53 | 2.23 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
16.89 | 20.82 | 14.11 | 8.21 | 10.99 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.02 | 0.05 | 0.00 | 3.90 |
|
Current Ratio
|
1.02 | 1.00 | 6.01 | 1.17 | 0.95 |
|
Quick Ratio
|
1.02 | 1.00 | 6.01 | -- | 0.95 |
|
Interest Coverage
|
34.10 | 8.52 | 49.62 | 1.52 | 1.39 |
Operating Efficiency Ratios
| CME Group Inc. Class A (CME) | Nasdaq (NDAQ) | MarketAxess Holdings (MKTX) | Morgan Stanley (MS) | Goldman Sachs Group Inc (GS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.30 | 12.81 | 13.99 | 0.00 | 473.74 |
|
Asset Turnover
|
0.02 | 0.26 | 0.33 | 0.08 | 0.04 |
|
Receivable days
|
33.95 | 43.67 | 173.30 | 319.05 | 796.01 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
30.54 | 23.43 | 169.20 | 2,188.06 | 1,265.07 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
